Weight Loss and Blood Pressure Reduction in Obese Subjects in Response to Nutritional Guidance Using Information Communication Technology

References

• Park HS, Lee K. Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med 2004; 22: 266–272
   Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare of Japan. The National Health and Nutrition Survey in Japan, 2004. Dai-Ichi Shuppan Publishing. Co., Ltd. 2006; 38–41
   Google Scholar
• Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999; 38: 202–206
   PubMed Web of Science ®Google Scholar
• Bo I, Kaj L, Peter A, Michael N, Tiinamaija T, Marja-Riitta T, Bjorn F, Leif G. Cardiovascular morbidity and mortality associated with the metabolic syndrome. diabetes care 2001; 24: 683–689
   PubMed Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716
   PubMed Web of Science ®Google Scholar
• Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245–1250
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Itakura H. The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: Sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study. Hypertens Res 2005; 28: 879–887
   PubMed Web of Science ®Google Scholar
• Tate DF, Wing RR, Winett RA. Using internet technology to deliver a behavioral weight loss program. JAMA 2001; 285: 1172–1177
   PubMed Web of Science ®Google Scholar
• Wylie-Rosett J, Swencionis C, Ginsberg M, Cimino C, Wassertheil-Smoller S, Caban A, Segal-Isaacson CJ, Martin T, Lewis J. Computerized weight loss intervention optimizes staff time: the clinical and cost results of a controlled clinical trial conducted in a managed care setting. J Am Diet Assoc 2001; 101: 1155–1162
   PubMed Web of Science ®Google Scholar
• Harvey-Berino J, Pintauro S, Buzzell P, DiGiulio M, Casey Gold B, Moldovan C, Ramirez E. Does using the Internet facilitate the maintenance of weight loss?. Int J Obes 2002; 26: 1254–1260
   PubMed Web of Science ®Google Scholar
• Tate DF, Jackvony EH, Wing RR. Effects of internet behavioral counseling on weight loss in adults at risk for type 2 diabetes. JAMA 2003; 289: 1833–1836
   PubMed Web of Science ®Google Scholar
• Harvey-Berino J, Pintauro S, Buzzell P, Gold EC. Effect of internet support on the long-term maintenance of weight loss. Obes Res 2004; 12: 320–329
   PubMedGoogle Scholar
• Womble LG, Wadden TA, McGuckin BG, Sargent SL, Rothman RA, Krauthamer-Ewing ES. A randomized controlled trial of a commercial internet weight loss program. Obes Res 2004; 12: 1011–1018
   PubMedGoogle Scholar
• Goulis DG, Giaglis GD, Boren SA, Lekka I, Bontis E, Balas EA, Maglaveras N, Avramides A. Effectiveness of home-centered care through telemedicine applications for overweight and obese patients: a randomized controlled trial. Int J Obes 2004; 28: 1391–1398
   PubMed Web of Science ®Google Scholar
• Tate DF, Jackvony EH, Wing RR. A randomized trial comparing human e-mail counseling, computer-automated tailored counseling, and no counseling in an internet weight loss program. Arch Intern Med 2006; 166: 1620–1625
   PubMed Web of Science ®Google Scholar
• Wing RR, Tate DF, Gorin AA, Raynor HA, Fava JL. A self-regulation program for maintenance of weight loss. N Engl J Med 2006; 355: 1563–1571
   PubMed Web of Science ®Google Scholar
• Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension. A 10-year follow-up study. Circulation 1998; 98: 1892–1897
   PubMed Web of Science ®Google Scholar
• Malcolm A, Gwen M, Kevin J. Home blood pressure monitoring: its effect on the management of hypertension in general practice. Br J Gen Pract 1999; 49: 725–728
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. JACC 2005; 46: 508–515
   Google Scholar
• Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Tsuji I, Imai Y. White-coat hypertension as a risk factor for the development of home hypertension. Arch Intern Med 2005; 165: 1541–1546
   PubMed Web of Science ®Google Scholar
• Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002; 40: 795–796
   PubMed Web of Science ®Google Scholar
• Nakamoto H, Kawamoto A, Tanabe Y, Nakagawa Y, Nishida E, Akiba T, Suzuki H. Telemedicine system using a cellular telephone for continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2003; 19: 124–129
   PubMedGoogle Scholar
• Nakamoto H, Nishida E, Ryuzaki M, Sone M, Yoshimoto M, Itagaki K. Blood pressure monitoring by cellular telephone in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 2004; 20: 105–110
   PubMedGoogle Scholar
• Cho JH, Chang SA, Kwon HS, Choi YH, Ko SH, Moon SD, Yoo SJ, Song KH, Son HS, Kim HS, Lee WC, Cha BY, Son HY, Yoon KH. Long-term effect of the internet-based glucose monitoring system on HbA1c reduction and glucose stability. Diabetes Care 2006; 29: 2625–2631
   PubMed Web of Science ®Google Scholar
• Maeda H, Yamamoto R, Hirao K, Tochikubo O. Effects of agar (kanten) diet on obese patients with impaired glucose tolerance and type 2 diabetes. Diabetes Obes Metab 2005; 7: 40–46
   PubMed Web of Science ®Google Scholar
• Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 2006; 13: 202–208
   PubMed Web of Science ®Google Scholar